Beste pädiatrische Onkologen - TOP-400 Ärzte

• Spezialisiert auf pädiatrische Onkologie und Behandlung von Krebsarten wie Leukämie, Lymphomen und Hirntumoren.
• International ausgebildet, um die Fähigkeiten in der pädiatrischen Krebsbehandlung weltweit zu verbessern.
• Hält sich an evidenzbasierte Protokolle, um hohe Erfolgsraten in der pädiatrischen Onkologie zu erzielen.
• Anerkannt für herausragende Leistungen in der pädiatrischen Onkologie mit bemerkenswerten Ärzterankings.
• Verfügt über Zertifizierungen für pädiatrische Onkologie und gewährleistet so qualifizierte Fachkenntnisse in der Krebsbehandlung von Kindern.
• Aktives Mitglied professioneller Fachgesellschaften für pädiatrische Onkologie, das zu fortschrittlichen Pflegestandards beiträgt.
• Bietet Online-Konsultationen und ermöglicht den Zugang zu spezialisierter pädiatrischer Onkologie-Betreuung aus der Ferne.

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

Pädiatrischer Hämatologe-Onkologe, Spezialist für Knochenmarktransplantationen

Leiter der Abteilung für pädiatrische Onkologie

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21

Estetik Cerrahi: Deneyimli cerrahlarımızla, güncel teknikleri kullanarak estetik cerrahi hizmetleri sunuyoruz. Her bireyin ihtiyacına özel çözümler üreterek, doğal ve estetik sonuçlar elde etmeyi amaçlıyoruz.

Saç, Sakal ve Kaş Ekimi: Saç dökülmesi, seyrek sakal ya da kaş problemleriyle mücadele edenlere özel çözümler sunuyoruz. Uzman ekibimiz, kişinin yüz hatlarına uygun doğal sonuçlar elde etmeyi hedefler.

Dolgu Uygulamaları: Yüz gençleştirme ve kontürleme amacıyla kullanılan dolgu uygulamalarını, uzman estetik cerrahlarımız ile güvenli bir şekilde gerçekleştiriyoruz. Doğallığı ön planda tutan yaklaşımımızla, müşterilerimize istedikleri görünüme kavuşmalarında yardımcı oluyoruz.

Dr Reema Arora has been a national and international trainer in BOTOX® and Fillers for the past 18 years. She has worked with Allergan India Pvt Ltd. as Medical Head- Facial Aesthetics and has the credit of training over 1500 Dermatologist and Plastic surgeons in the art of facial rejuvenation with injectables.
Dr. Arora has single handedly revolutionized the use of Botox and dermal fillers in India with new innovations and focus on Indian faces. She has perfected the art of using Botox, Juvederm, and Voluma amongst other injectables to rejuvenate, enhance and treat the whole face including -facial asymmetries, defining various facial features like the nose, jaw, lips and resolving excessive sweating. 

Dr Reema Arora has been a national and international trainer in BOTOX® and Fillers for the past 18 years. She has worked with Allergan India Pvt Ltd. as Medical Head- Facial Aesthetics and has the credit of training over 1500 Dermatologist and Plastic surgeons in the art of facial rejuvenation with injectables.
Dr. Arora has single handedly revolutionized the use of Botox and dermal fillers in India with new innovations and focus on Indian faces. She has perfected the art of using Botox, Juvederm, and Voluma amongst other injectables to rejuvenate, enhance and treat the whole face including -facial asymmetries, defining various facial features like the nose, jaw, lips and resolving excessive sweating.

Dr. Arora made the switch to cosmetic medicine in 2006 following her passion for Aesthetics. She has been trained in Australia, Korea and Singapore with acclaimed dermatologist and plastic surgeons. Dr. Reema Arora is a medical graduate from St John’s Medical College Hospital and a postgraduate in Paediatrics.She went on to do her Masters in Aesthetic Medicine from London in 2018 and has gone on to become a brand in herself in Facial Aesthetics, continuously perfecting her well honed skills. Being India’s leading Rejuvenation expert for over 8 years, Dr. Reema Arora has always been a pioneer in Injectables. She constantly updates her techniques and extensive knowledge of the subject by attending training workshops and seminars.

Professor Dr. Gökmen
General Surgeon

EDUCATION

• 1994: Bursa Uludağ University - Faculty of Medicine, MD
• 2000: Istanbul Okmeydanı Training and Research Hospital - General Surgery Specialization, MS

EXPERTISE

• Gastric Bypass / RNY
• Mini Gastric Bypass / MGB
• Gastric Sleeve / Fundectomy
• Gastric Banding / Bariatric Surgeries
• Gastroscopic Procedures
• Gastric Balloon Placement
• Gastric Elipse Balloon
• Gastric Botox
• Sad-S Surgery
• Distalization of RYGB
• Hernia Repair
• First and Only Operator in Turkey

TRAINING AND COURSES

• Master of Surgery:
  • Temple University School of Medicine - Laparoscopic and Bariatric Surgery Courses
  • European Institute of Telesurgery - Bariatric and Metabolic Surgery Courses (2012)
  • European Institute of Telesurgery - Advanced Colorectal Surgery Courses (2012)
  • Case Da Vinci Robotic Surgery Courses (2014)
  • Venous Diseases and Endovascular Surgery Course (2015)

MEMBERSHIPS

• UTACD: Turkish Association of Trauma and Emergency Surgery
• TSCRS: Turkish Society of Colon and Rectal Surgery
• TSA: Turkish Surgical Association

NUMBER OF CASES

• Experience of over 40,000 surgical cases in 29 years, including:
  • 20,000 Bariatric Surgeries
  • Approximately 107+ Laparoscopic Colon Resections
  • Approximately 100+ Laparoscopic Total Gastric Resections
  • Approximately 1,150+ Laparoscopic Sleeve Gastrectomies
  • Approximately 780+ Laparoscopic Mini Gastric Bypasses
  • Approximately 1,200+ Laparoscopic Roux-en-Y Gastric Bypasses
  • Approximately 1,550+ Laparoscopic Cholecystectomies

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.